tiprankstipranks
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
US Market
Holding PRAX?
Track your performance easily

Praxis Precision Medicines (PRAX) Ownership - Who Owns Praxis Precision Medicines?

554 Followers

Praxis Precision Medicines (PRAX) Ownership Overview

10.51%13.65%48.89%13.05%13.90%
10.51% Insiders
48.89% Other Institutional Investors
13.05% ETFs
13.90% Public Companies and Individual Investors
The ownership structure of Praxis Precision Medicines (PRAX) stock is a mix of institutional, retail, and individual investors. Approximately 75.59% of the company’s stock is owned by Institutional Investors, 10.51% is owned by Insiders, and 13.90% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 15, 2024
xxxxxxxxxxxxx
$424275
Nov 15, 2024
Alex Nemiroff
Gc & Secretary
xxxxxxxxxxxxx
$660768

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,789,226Insider9.60%130,166,192
1,164,035Institution6.25%84,683,546
974,222Institution5.23%70,874,651
773,650Institution4.15%56,283,038
761,955Institution4.09%55,432,226
705,629Institution3.79%51,334,510
402,448Institution2.16%29,278,092
323,105Institution1.73%23,505,889
290,810Institution1.56%21,156,428
264,511Institution1.42%19,243,175

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
773,650Institution4.15%56,283,038
290,810Institution1.56%21,156,428
264,511Institution1.42%19,243,175
240,409Institution1.29%17,489,755
183,818Institution0.99%13,372,760
183,651Institution0.99%13,360,610
147,815Institution0.79%10,753,541
138,504Institution0.74%10,076,166
87,676Institution0.47%6,378,429
54,253Institution0.29%3,946,906

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
472,946Institution2.54%34,406,822
541,275Institution2.90%31,144,964
373,677Institution2.00%26,721,642
254,313Institution1.36%14,633,170
154,478Institution0.83%11,238,275
80,443Institution0.43%5,752,479
75,830Institution0.41%5,422,603
79,107Institution0.42%4,551,817
49,357Institution0.26%3,541,858
39,595Institution0.21%2,880,536

FAQ

Who Owns Praxis Precision Medicines (PRAX)?
According to the latest TipRanks data, approximately 48.89% of the company's stock is held by institutional investors, 10.51% is held by insiders, and 13.90% is held by retail investors.
    What percentage of Praxis Precision Medicines (PRAX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 48.89% of Praxis Precision Medicines (PRAX) stock is held by institutional investors.
      What percentage of Praxis Precision Medicines (PRAX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 13.90% of Praxis Precision Medicines (PRAX) stock is held by retail investors.
        Who owns the most shares of Praxis Precision Medicines (PRAX)?
        Steven A. Cohen owns the most shares of Praxis Precision Medicines (PRAX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis